Search results
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 1 day agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 1 day agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 1 day agoIn Diabetes, Januvia/Janumet (diabetes) franchise sales declined 21% year over year to $670 million....
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 23 hours agoSales of human papillomavirus vaccine Gardasil jumped 14% to $2.25 billion. That narrowly topped...
20 Fastest Growing Health Tech Companies in the World
Insider Monkey via Yahoo Finance· 1 day agoIn this article, we will be taking a look at the 20 fastest growing health tech companies in the...
Sigma Planning Corp Sells 25,974 Shares of Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 4 days agoSigma Planning Corp reduced its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 56.2% during the 4th quarter, according to the company in its most recent Form 13F filing with ...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 1 day agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
Will Higher Keytruda Sales Drive Merck's Q1
Forbes· 3 days agoMerck (NYSE: MRK) will report its Q1 2024 results on Thursday, April 25. As usual, Keytruda will be the driving growth for Merck with quarterly sales...
How Many More Ozempic-like Drugs Are In the Pipeline — Here’s What Researchers Are Working On
Inverse· 6 days agoFew drugs have achieved the stardom that semaglutide, marketed in the United States as Ozempic or...
Q3 2024 Earnings Forecast for Merck & Co., Inc. Issued By Leerink Partnrs (NYSE:MRK)
ETF DAILY NEWS· 5 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) – Research analysts at Leerink Partnrs raised their Q3 2024 earnings per share estimates for Merck & Co., Inc. in a report released on Friday, April ...